We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.6%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$8.89B
AUM Growth
+$1.45B
Cap. Flow
+$1.09B
Cap. Flow %
12.29%
Top 10 Hldgs %
26.12%
Holding
266
New
39
Increased
114
Reduced
52
Closed
27

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$63.8M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$50M
3
VR
Validus Hold Ltd
VR
+$44.1M
4
PBYI icon
Puma Biotechnology
PBYI
+$33.5M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$30.4M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$59.3M
2
DHR icon
Danaher
DHR
+$44.2M
3
HOLX
Hologic
HOLX
+$42M
4
BDX icon
Becton Dickinson
BDX
+$40.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$38.7M

Sector Composition

Rank Sector Weight
1 Financials 21.97%
2 Healthcare 21.33%
3 Technology 19.13%
4 Communication Services 9.13%
5 Industrials 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PYPL icon
51
PayPal
PYPL
$49.5B
$48.1M 0.54%
751,563
+69,474
+10% +$4.16M
EXPE icon
52
Expedia Group
EXPE
$31.2B
$48.1M 0.54%
334,063
+46,937
+16% +$6.95M
HUM icon
53
Humana
HUM
$46.7B
$47.6M 0.54%
195,436
– –
Y
54
DELISTED
Alleghany Corp
Y
$47.1M 0.53%
85,000
+7,250
+9% +$4.23M
OLED icon
55
Universal Display
OLED
$3.71B
$47M 0.53%
365,142
-44,178
-11% -$5.34M
AMD icon
56
CALL
Advanced Micro Devices
AMD
$851B
$47M 0.53%
3,690,000
-1,469,000
-28% -$19.2M
LVNTA
57
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$45M 0.51%
782,532
– –
ACN icon
58
Accenture
ACN
$89.9B
$45M 0.51%
333,363
– –
HUBS icon
59
HubSpot
HUBS
$10.5B
$45M 0.51%
535,188
+24,493
+5% +$1.75M
CRM icon
60
Salesforce
CRM
$134B
$43.5M 0.49%
465,497
-40,000
-8% -$3.68M
RHT
61
DELISTED
Red Hat Inc
RHT
$43.1M 0.49%
389,241
+40,660
+12% +$4.16M
PBYI icon
62
Puma Biotechnology
PBYI
$406M
$43.1M 0.49%
+360,000
New +$33.5M
LOXO
63
DELISTED
Loxo Oncology, Inc
LOXO
$42.4M 0.48%
460,000
+90,000
+24% +$6.99M
XLNX
64
DELISTED
Xilinx Inc
XLNX
$42.3M 0.48%
597,465
+36,800
+7% +$2.4M
PGR icon
65
Progressive
PGR
$124B
$41.9M 0.47%
865,000
+33,300
+4% +$1.56M
ATVI
66
DELISTED
Activision Blizzard
ATVI
$41.5M 0.47%
643,577
+32,163
+5% +$2.01M
ADBE icon
67
Adobe
ADBE
$89.5B
$41.1M 0.46%
275,264
-24,459
-8% -$3.65M
PFPT
68
DELISTED
Proofpoint, Inc.
PFPT
$41M 0.46%
469,763
+23,300
+5% +$2.07M
AMG icon
69
Affiliated Managers Group
AMG
$9.46B
$39.9M 0.45%
210,018
+32,786
+18% +$5.83M
NVDA icon
70
NVIDIA
NVDA
$5.01T
$39.9M 0.45%
8,920,320
-222,240
-2% -$924K
XLRN
71
DELISTED
Acceleron Pharma
XLRN
$39.7M 0.45%
1,065,000
-10,000
-0.9% -$347K
OXFD
72
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$39.7M 0.45%
2,365,022
+262,545
+12% +$4.27M
RVNC
73
DELISTED
Revance Therapeutics, Inc.
RVNC
$39.2M 0.44%
1,424,213
+127,842
+10% +$3.1M
NOW icon
74
ServiceNow
NOW
$102B
$39M 0.44%
1,659,565
+231,165
+16% +$5.14M
LEXEA
75
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$38.8M 0.44%
731,210
– –
1 2
3
4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Polar Capital held 266 positions worth $8.89B, up 20% from $7.43B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Polar Capital deployed $1.09B of net new capital in Q3 2017, opening 39 new positions and adding to 114 existing holdings. Its largest new stake was Puma Biotechnology: 360,000 shares worth $43.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Medtronic, an estimated $59.3M trimmed.

  • Polar Capital's largest Q3 2017 buy was Puma Biotechnology: 360,000 shares worth $43.1M.
  • Polar Capital added most to Amgen in Q3 2017, an estimated $63.8M increase.
  • Polar Capital's biggest Q3 2017 reduction was Medtronic, cutting an estimated $59.3M.
  • Polar Capital fully exited Hologic in Q3 2017, selling an estimated $42M.
  • Polar Capital's ten largest holdings make up 26% of its $8.89B portfolio in Q3 2017.
  • Polar Capital opened 39 new positions and closed 27 in Q3 2017.
  • Polar Capital's portfolio value rose 20% quarter-over-quarter to $8.89B.

Based on Polar Capital's 13F filing for Q3 2017, filed 14 Nov 2017.